anti-EpCAM-IL2 immunocytokine (Provenance Biopharmaceuticals)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-EpCAM-IL2 immunocytokine (Provenance Biopharmaceuticals)
Drug Alias Nameanti-EpCAM-IL2
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-2 receptor antagonistsEpithelial cell adhesion molecule inhibitors
TargetsEpithelial cell adhesion moleculeInterleukin-2 receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProvenance Biopharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProvenance Biopharmaceuticals
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A